Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fortrea Holdings Inc. ( (FTRE) ) has shared an update.
On September 19, 2025, Fortrea Holdings Inc. announced the appointment of William J. Sharbaugh as a Class III director, effective September 22, 2025, expanding the board to eight members. Mr. Sharbaugh brings over 30 years of experience in the pharmaceutical industry, having held executive roles at companies like PPD, Inc., and Bristol-Myers Squibb. His appointment is expected to enhance Fortrea’s strategic execution and stakeholder value as the company continues to focus on delivering life-changing treatments globally.
The most recent analyst rating on (FTRE) stock is a Hold with a $9.50 price target. To see the full list of analyst forecasts on Fortrea Holdings Inc. stock, see the FTRE Stock Forecast page.
Spark’s Take on FTRE Stock
According to Spark, TipRanks’ AI Analyst, FTRE is a Neutral.
Fortrea Holdings Inc. faces significant financial challenges, particularly in profitability and cash flow, which heavily impact its overall score. While technical analysis shows bullish momentum, valuation concerns and mixed earnings call results temper optimism. The expansion of the Inducement Award Plan is a positive corporate event, but its impact is limited compared to the financial issues.
To see Spark’s full report on FTRE stock, click here.
More about Fortrea Holdings Inc.
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. The company partners with biopharmaceutical, biotechnology, medical device, and diagnostic companies to drive healthcare innovation, offering phase I-IV clinical trial management, clinical pharmacology, and consulting services. Fortrea leverages over three decades of experience across more than 20 therapeutic areas and operates in about 100 countries.
Average Trading Volume: 2,098,494
Technical Sentiment Signal: Sell
Current Market Cap: $919.8M
For a thorough assessment of FTRE stock, go to TipRanks’ Stock Analysis page.